Anticoagulation Bleeding Mortality and Pathology in Hospitalized Patients with COVID-19

Nadkarni, G., Lala, A., Bagiella, E., et al.. (2021). Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients with COVID-19. (Added 12/23/2020.) Journal of the American College of Cardiology. 76(16):1815-1826.
This study, of more than 4,000 patients in 5 New York City hospitals between March 1, 2020 and April 30, 2020, found a 50% reduced hazard of in-hospital mortality and 30% reduced hazard of intubation among those with therapeutic and prophylactic anticoagulation (AC) in comparison to those with no AC. Autopsies suggested that clinical estimates thromboembolic disease may be underestimated.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.